Please assess the completion status of the following clinical trial:

Trial Title: Trial of Levetiracetam in Patients With Primary Brain Tumors and Symptomatic Seizures Who Undergo Surgery

Study Design Characteristics:
- Allocation: NON_RANDOMIZED
- Intervention Model: SINGLE_GROUP
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: NONE
- Phase: PHASE4
- Number of Arms: 1.0

Eligibility Criteria:
Inclusion Criteria:~* age ≥ 18 years~* suspected primary brain tumor by imaging~* planned bioptical or cytoreductive surgery of the tumor~* symptomatic epilepsy~* Karnofsky performance score ≥ 70%~* women with child bearing potential must perform sufficient contraception~* sufficient haematologic, hepatic and renal function by laboratory testing~Exclusion Criteria:~* treatment with other antiepileptic drugs other than levetiracetam in the last seven days before surgery~* known allergic reaction to levetiracetam or other serious side effects~* known, not tumor-induced, epilepsy~* previous brain surgery~* dementia~* participation in another clinical trial~* addiction to drugs or alcohol~* pregnant or breast feeding women

- Gender: ALL
- Minimum Age: 18 Years
- Maximum Age: None
- Healthy Volunteers: f

Study Arms:
- 1 (Type: OTHER): None

Based on this trial design, predict the completion outcome and termination type (if applicable).